Results 41 to 50 of about 662,207 (147)

Importance of sodium-glucose cotransporter 2 inhibitor use in diabetic patients with acute heart failure

Therapeutic Advances in Cardiovascular Disease, 2019
Background: It is known that once heart failure occurs in older patients with diabetes, the overall prognosis is extremely poor. We investigated whether early initiation of SGLT2 inhibitor therapy after admission was beneficial for diabetic patients ...
Takahiro Kambara, Rei Shibata, Hiroyuki Osanai, Yoshihito Nakashima, Hiroshi Asano, Toyoaki Murohara, Masayoshi Ajioka   +6 more
doaj   +1 more source

SGLT2 inhibitors as potentially helpful drugs in PI3K inhibitor-induced diabetes: a case report

, 2021
Background Hyperglycemia is the most common side-effect of phosphatidylinositol 3-kinase (PI3K) inhibitors that are approved for the treatment of some advanced or metastatic breast cancers.
Ramillon-Cury, Clotilde, Audrey Bégu-Le Corroller, Béliard, Sophie, Sophie Béliard, Pascale Silvestre-Aillaud, Sahakian, Nicolas, Lauranne Cattieuw, Cattieuw, Lauranne, Nicolas Sahakian, Valéro, René, Corroller, Audrey Bégu-Le, Silvestre-Aillaud, Pascale, Clotilde Ramillon-Cury, René Valéro   +13 more
core   +1 more source

Practical Considerations and Implementation of Sodium-Glucose Co-Transporter-2 Inhibitors in Chronic Kidney Disease: Who, When, and How? A Position Statement by Nephrologists

Journal of Primary Care & Community Health
Introduction: There remains an unmet need to reduce kidney and cardiovascular risk in patients with chronic kidney disease (CKD). This report is therefore intended to provide real-world clinical guidance to primary care providers on sodium-glucose co ...
Anjay Rastogi, Ashté Collins, Ellie Kelepouris, Wayne Kotzker, John P. Middleton, Minesh Rajpal, Prabir Roy-Chaudhury, Glenn M. Chertow   +7 more
doaj   +1 more source

A Novel Therapeutic Approach to Type 2 Diabetes Mellitus by SGLT2 Inhibitor [PDF]

, 2015
Article信州医学雑誌 63(1):9-18(2015)journal ...
佐藤, 吉彦
core   +1 more source

CETP and SGLT2 inhibitor combination therapy improves glycemic control

, 2023
Importance: Cholesteryl ester transfer protein (CETP) inhibition has been associated with decreased risk of new-onset diabetes in past clinical trials exploring their efficacy in cardiovascular disease and can potentially be repurposed to treat metabolic
Davidson, Michael H., Sun, Patrick, Ditmarsch, Marc, Khomtchouk, Bohdan B., Kastelein, John J. P.   +4 more
core   +1 more source

BDNF Levels and Cognitive Function in Patients with Type 2 Diabetes Treated with SGLT2 Inhibitors [PDF]

Objective: As cognitive impairment becoming more widely recognized as a complication of type 2 diabetes mellitus (T2DM), it is discussed in the literature that antihyperglycemic treatment may also improve cognitive functions.
Esra ÇALIŞICI, Betül SÜMBÜL ŞEKERCİ, Abdüsselam ŞEKERCİ, Şeymanur DEMİRHAN   +3 more
core   +1 more source

COVID-19 Precipitating Euglycaemic Diabetic Ketoacidosis with SGLT2 Inhibitor Use [PDF]

, 2020
Objective: To describe a patient who developed euglycaemic diabetic ketoacidosis (DKA) in the setting of SGLT2 inhibitor use precipitated by COVID-19.Patient and methods: A 52-year-old male with type II diabetes on empagliflozin and no history of DKA ...
Caskey, Rachel N, Fang, Jiali, Genco, Matthew   +2 more
core   +1 more source

SGLT2 Inhibitor–Induced Euglycemic Diabetic Ketoacidosis: A Case Report

Kidney Medicine, 2020
Euglycemic diabetic ketoacidosis is a rare but serious adverse effect of sodium-glucose cotransporter 2 (SGLT2) inhibitors. We present a case of a woman in her 40s with type 2 diabetes mellitus hospitalized for revascularization for moyamoya disease who ...
Katherine M. Wang, Robert T. Isom
doaj   +1 more source

SGLT2 inhibitor plus DPP-4 inhibitor as combination therapy for type 2 diabetes: A systematic review and meta-analysis

, 2018
To assess the efficacy and safety of sodium‐glucose co‐transporter 2 (SGLT2) inhibitors plus a dipeptidyl peptidase‐4 (DPP‐4) inhibitor in patients with type 2 diabetes mellitus (T2DM), we performed a systematic review and meta‐analysis of 14 randomized ...
Huilin Tang, Shi, Weilong, Wang, Tiansheng, Dandan Li, Tiansheng Wang, Tang, Huilin, Weilong Shi, Li, Dandan   +7 more
core   +1 more source

Comparative effectiveness of oral antidiabetic drugs in preventing cardiovascular mortality and morbidity: A network meta-analysis.

PLoS ONE, 2017
In the Guidance for Industry from the Food and Drug Administration in 2008, excess cardiovascular risk should be ruled out in trials of all new antidiabetic drugs; however, relatively few studies have focused on cardiovascular safety with antidiabetic ...
Gyeongsil Lee, Seung-Won Oh, Seung-Sik Hwang, Ji Won Yoon, Sungchan Kang, Hee-Kyung Joh, Hyuktae Kwon, Jeehyun Kim, Danbee Park   +8 more
doaj   +1 more source